Regulation & policy

Supplements 101: What are peptides?

NI+Supplements 101: What are peptides?

By Lauren Nicolle

The surge in GLP-1 drug use has brought peptides from a niche research area into the mainstream, sparking growing interest across nutrition and health, but confusion remains about what they are and how they are regulated.

ASA ruling on blurred reviews reveals strict criteria on claims

ASA ruling on blurred reviews reveals strict criteria on claims

By Olivia Haslam

A new ruling from the Advertising Standards Authority (ASA) over The Turmeric Co.’s use of blurred customer testimonials reinforces the agency’s strict stance on disease claims, reminding the industry that even implied treatment claims are off-limits.

Safety in question: What is the future of berberine?

NI+Safety in question: What is the future of berberine?

By Lauren Nicolle

Earlier this year, the European Food Safety Authority (EFSA) concluded that no safe intake level of berberine could be established, triggering a consultation to determine its regulatory status. Now, there is concern that this could lead to tighter...

Europe to ban Bifidobacterium? Probably not

Guest article

NI+Europe to ban Bifidobacterium? Probably not

By Dr. Luis Gosálbez, Managing Director, Sandwalk Bioventures

On July 3, the European Food Safety Authority released an external scientific report flagging six food ingredients as possible emerging risks. To the surprise (and panic) of many, one of these ingredients was the (entire) bacterial genus Bifidobacterium.

Regulators clamp down on vitamin B6 as toxicity debate grows

NI+Regulators clamp down on vitamin B6 as toxicity debate grows

By Lauren Nicolle

Vitamin B6 is essential to human health, but excessive doses may cause serious side effects. As a growing number of countries tighten oversight of vitamin B6 supplements, debate is intensifying over whether the restrictions are proportionate to the risk.

‘Unmatched’: Nutra Healthspan Summit returns for November 2026

‘Unmatched’: Nutra Healthspan Summit returns for November 2026

By Stephen Daniells

Described by one attendee as “an event with wall-to-wall speakers who delivered insightful, topical, useable information”, the Nutra Healthspan Summit is returning to London for its 2nd edition with more high-level content and networking opportunities.

Indian high court grants interim stay on ashwagandha leaf ban

News in brief

Indian high court grants interim stay on ashwagandha leaf ban

By Asia Sherman

The Karnataka High Court in Bangalore has temporarily stayed the Indian government’s restriction on the use of ashwagandha leaves issued last month after industry stakeholders challenged the rationale behind the blanket ban.

Timeline: Is CBD heading towards a frozen market in the UK?

NI+Timeline: Is CBD heading towards a frozen market in the UK?

By Nikki Hancocks

Recently published minutes from a closed Food Standards Agency board meeting indicate that CBD approvals will be delayed further and are unlikely to occur before the end of summer 2026, raising questions as to whether this could effectively freeze the...